Hepatology International is the official journal of the Asian Pacific Association for the Study of the Liver (APASL). This is a peer-reviewed journal featuring articles written by clinicians, clinical researchers and basic scientists is dedicated to research and patient care issues in hepatology. This journal will focus mainly on new and emerging technologies, cutting-edge science and advances in liver and biliary disorders.Types of articles published:-Original Research Articles related to clinical care and basic research-Review Articles-Consensus guidelines for diagnosis and treatment-Clinical cases, images-Selected Author Summaries-Video Submissions
《国际肝病》是亚太肝脏研究协会（APASL）的官方期刊。这是一本由临床医生、临床研究人员和基础科学家撰写的同行评审期刊，致力于肝病学的研究和患者护理问题。该杂志将主要关注新兴技术、前沿科学和肝胆疾病的进展。发表的文章类型：-与临床护理和基础研究相关的原创研究文章-综述文章-诊断和治疗的共识指南-临床病例、图像-选定作者摘要-视频提交
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09946-3
Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09964-1
Liver damage related to immune checkpoint inhibitors
来源期刊：Hepatology InternationalDOI：10.1007/s12072-018-9921-7
Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005–2016
来源期刊：Hepatology InternationalDOI：10.1007/s12072-018-09926-z
Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-10002-3
Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09967-y
Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09980-1
Chinese guidelines on the management of ascites and its related complications in cirrhosis
来源期刊：Hepatology InternationalDOI：10.1007/s12072-018-09923-2
Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09989-6
New drugs for NAFLD: lessons from basic models to the clinic
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-10001-4
Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09972-1
Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia–Pacific region
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09992-x
Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09982-z
Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09994-9
Sofosbuvir–velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09927-6
Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09987-8
Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09933-8
Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09966-z
Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥\u200910 cm): a multicenter propensity matching analysis
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09981-0
Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular–clinical analysis and potential targeted approach
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09954-3
MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09993-w
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09943-6
Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patients
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09941-8
Current status and perspectives for computer-aided ultrasonic diagnosis of liver lesions using deep learning technology
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09937-4
An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09969-w
Biliary features in liver histology of children with autoimmune liver disease
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09948-1
Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9–12 years) and adolescents
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09985-w
Pegylated-interferon consolidation treatment versus nucleos(t)ide analogue consolidation treatment in non-cirrhotic hepatitis B patients with hepatitis B e antigen seroconversion: an open-label pilot trial
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09957-0
The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose–response meta-analysis
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09952-5
The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09975-y
Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09956-1
Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-10003-2
Change in antibiotic regimen for emerging multidrug resistance in nosocomial ascitic fluid infection
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-10000-5
Ascitic fluid infection in children with liver disease: time to change empirical antibiotic policy
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09968-x
Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09930-x
SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09955-2
Bacteroides in colonic mucosa-associated microbiota affects the development of minimal hepatic encephalopathy in patients with cirrhosis
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09963-2
Laser capture microdissection: techniques and applications in liver diseases
来源期刊：Hepatology InternationalDOI：10.1007/s12072-018-9917-3
Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanisms
来源期刊：Hepatology InternationalDOI：10.1007/s12072-018-9920-8
Mutations in CYP2C9 and/or VKORC1 haplotype are associated with higher bleeding complications in patients with Budd–Chiari syndrome on warfarin
来源期刊：Hepatology InternationalDOI：10.1007/s12072-018-9922-6
Association between neutrophil–lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09965-0
Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09998-5
Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09990-z
Point shear wave elastography predicts fibrosis severity and steatohepatitis in alcohol-related liver disease
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-10009-w
Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09999-4
Association of acute-on-chronic liver failure with vascular liver diseases
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09958-z
Correction to: Antifibrotics in liver disease: are we getting closer to clinical use?
来源期刊：Hepatology InternationalDOI：10.1007/s12072-018-09924-1
New treatment-induced adverse effects we need to learn as modern hepatologists
来源期刊：Hepatology InternationalDOI：10.1007/s12072-019-09947-2
